Issued Patents 2021
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11103533 | Compositions and methods for treating cancer with anti-CD38 immunotherapy | Dina Schneider, Rimas J. Orentas, Boro Dropulic, Zhongyu Zhu | 2021-08-31 |
| 11078286 | Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use | Javed Khan, Sivasubramanian Baskar, Rimas J. Orentas, Zhongyu Zhu, Tai Chi Cheuk | 2021-08-03 |
| 11066479 | Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof | Mitchell Ho, Nan Li | 2021-07-20 |
| 11034757 | Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2021-06-15 |
| 11033620 | Combination therapies targeting tumor-associated stroma or tumor cells and microtubules | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2021-06-15 |
| 11033621 | Combination therapies targeting tumor-associated stroma or tumor cells | Saurabh Saha, Xiaoyan Zhang, Zhongyu Zhu, Brad St. Croix, Enrique Zudaire | 2021-06-15 |
| 10954291 | Monoclonal antibodies that specifically bind to matrilin-3 and their use | Jeffrey Baron, Crystal Sao Fong Cheung, Julian Chun Kin Lui, Zhongyu Zhu | 2021-03-23 |
| 10934360 | Human monoclonal antibodies against EPHA4 and their use | Nancy Yuk-Yu Ip, Kit Yu Fu, Wing Yu Fu, Tianlei Ying | 2021-03-02 |